SHA:688578 Revenue

In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.17B CNY with 45.36% growth. Shanghai Allist Pharmaceuticals had revenue of 1.44B in the quarter ending December 31, 2025, with 40.44% growth.

Revenue

5.17B

Revenue Growth

+45.36%

P/S Ratio

8.18

Revenue / Employee

3.65M

Employees

1,823

Market Cap

42.31B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.17B	1.61B	45.36%
Dec 31, 2024	3.56B	1.54B	76.29%
Dec 31, 2023	2.02B	1.23B	155.14%
Dec 31, 2022	791.00M	260.91M	49.22%
Dec 31, 2021	530.09M	529.53M	94,409.97%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pharmaron Beijing	13.54B
Shanghai RAAS Blood Products	7.95B
Hebei Changshan Biochemical Pharmaceutical	928.01M
Beijing Wantai Biological Pharmacy Enterprise	1.80B
Chongqing Zhifei Biological Products	10.91B
Haisco Pharmaceutical Group	4.27B
Sunshine Guojian Pharmaceutical (Shanghai)	4.20B
Asymchem Laboratories (Tianjin)	6.29B

Revenue Rankings